GeneDx Holdings (WGS) Profit After Tax Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 7.60% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -3.37% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.12% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 26.93% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 12.84% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -267.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -267.28% |
| Mar 31, 2026 | -884.96% |
| Dec 31, 2025 | -457.25% |
| Sep 30, 2025 | 2.78% |
| Jun 30, 2025 | 136.95% |
| Mar 31, 2025 | 68.32% |
| Dec 31, 2024 | 119.51% |
| Sep 30, 2024 | 81.43% |
| Jun 30, 2024 | 37.92% |
| Mar 31, 2024 | 66.60% |
| Dec 31, 2023 | 91.79% |
| Sep 30, 2023 | 45.49% |
| Jun 30, 2023 | 45.51% |
| Mar 31, 2023 | 20.69% |
| Dec 31, 2022 | -668.35% |
| Sep 30, 2022 | -337.03% |
| Jun 30, 2022 | -85.75% |
| Mar 31, 2022 | 59.90% |
| Dec 31, 2021 | 68.03% |
| Sep 30, 2021 | 157.81% |